Skip to content

Veraxa Biotech AG - Post de-SPAC (VRXA) Insider Trading -- Recent Executive & Director Transactions

5 insiders reported 6 Form 4 transactions for Veraxa Biotech AG - Post de-SPAC (VRXA) over the past 18 months (most recent 2026-10-29). Recent activity: Gruninger Marc (Director) Buy 867 shares, Gruninger Marc (Director) Buy 9,133 shares, Ziegler Christoph Samuel (Director) Buy 30,000 shares, Hosseinion Warren (Director) Buy 6,024 shares, Antz Christoph Rudiger (Chief Executive Officer) Buy 5,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-10-29Gruninger MarcDirectorBuy867$850
2026-10-29Gruninger MarcDirectorBuy9,133$9,133
2026-10-21Ziegler Christoph SamuelDirectorBuy30,000$32,700
2026-09-29Hosseinion WarrenDirectorBuy6,024$10,060
2026-08-31Antz Christoph RudigerChief Executive OfficerBuy5,000$7,650
2026-08-31Baumann Oliver RolfDirectorBuy50,000$75,000

Source: SEC Form 4 filings · as of 2026-10-29